Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer’s Research

Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer’s Research

Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer’s Research Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Alzheimer’s Association

Application Deadline: October 1, 2015

The American Academy of Neurology, the American Brain Foundation, and the Alzheimer’s Association are pleased to announce a fellowship to support clinical research training in Alzheimer’s. The fellowship is supported by the Alzheimer’s Association, the American Academy of Neurology, and the American Brain Foundation. Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of a Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the Clinical Research Training Fellowship, fellows are required to submit a revised budget for review or may need to forfeit the rest of the award. Only direct costs will be funded by this fellowship.

IMPORTANT DATES October 1, 2015: Application deadline January 2016: Notification of recipients July 1, 2016: Funding begins ELIGIBILITY 1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases. 2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority. EVALUATION AND SELECTION Applications are evaluated by members of the Clinical Research Subcommittee, Translational Neuroscience Subcommittee, and various ad-hoc reviewers based on the following criteria: • Applicant’s ability and promise as a clinician-scientist based on prior record of achievement and career plan, letters of reference, and curriculum vitae (30 percent) • Quality and nature of the training to be provided and the institutional, departmental, and mentor-specific training environment (30 percent) • Quality and originality of the research plan (40 percent)

For More Information: http://www.alz.org/research/downloads/prog-announce-Katzman.pdf

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s